Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Assma Ben Aïssa

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Praxis|March 1, 2023
Immunotherapy in Melanoma: Highlights for the General PractitionerAssma Ben Aïssa
Revue Medicale Suisse|May 19, 2021
[CAR-T Cells in solid tumours: present and future]Assma Ben Aïssa, Maria-Viviana Niculescu, Denis Migliorini
Revue Medicale Suisse|June 14, 2013
[Vademecum of skeletal complications of malignancy]Céline Py, Pierre-Yves Dietrich, Assma Ben Aïssa
Praxis|March 1, 2023
Cardiovascular, Renal and Pulmonary Toxicity of Immune Checkpoint Inhibitors in Cancer: What the GP Should KnowLaure Smekens, Vassilis Genoud, Nita Usdin, et al.
Revue Medicale Suisse|May 18, 2026
[Cutaneous squamous cell carcinoma, what you should know in 2026]Michaël Ghose, Edouard Romano, Jöri Puenchera, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Praxis|March 1, 2023
Immunotherapy in Melanoma: Highlights for the General PractitionerAssma Ben Aïssa
Revue Medicale Suisse|May 19, 2021
[CAR-T Cells in solid tumours: present and future]Assma Ben Aïssa, Maria-Viviana Niculescu, Denis Migliorini
Revue Medicale Suisse|June 14, 2013
[Vademecum of skeletal complications of malignancy]Céline Py, Pierre-Yves Dietrich, Assma Ben Aïssa
Praxis|March 1, 2023
Cardiovascular, Renal and Pulmonary Toxicity of Immune Checkpoint Inhibitors in Cancer: What the GP Should KnowLaure Smekens, Vassilis Genoud, Nita Usdin, et al.
Revue Medicale Suisse|May 18, 2026
[Cutaneous squamous cell carcinoma, what you should know in 2026]Michaël Ghose, Edouard Romano, Jöri Puenchera, et al.
Pageof 1